Director Noel R. Holland of Columbia Financial, Inc./MD/ filed a Form 4 on August 11, 2026, disclosing a non-derivative securities acquisition in common stock dated August 7, 2026, on NASDAQ:CLBK.
A Form 4 filed with the SEC on August 11, 2026, discloses that Alister Cowan, a director of Chemours Co (NYSE:CC), purchased 13,000 shares of Chemours common stock on August 7, 2026.
Sean P. Duffy, Chief Executive Officer and Director of Omada Health, Inc. (NASDAQ:OMDA), filed a Form 4 on August 11, 2026, reporting option exercises and open-market sales of common stock executed on August 7 and August 10, 2026, pursuant to a Rule 10b5-1 trading …
A Form 4 filed on August 11, 2026, discloses that Michael Robert Foley, President of Titanium Technologies at Chemours Co (NYSE:CC), purchased 1,934.2313 shares of Chemours common stock on August 7, 2026.
Steven I. Sarowitz, a director and 10% owner of Paylocity Holding Corp (NASDAQ:PCTY), filed a Form 4 on August 11, 2026, disclosing the sale of 32,972 shares of common stock on August 7, 2026, under a pre-established Rule 10b5-1 trading plan.
Director Robert Chess filed a Form 4 with the SEC on August 11, 2026, reporting the exercise of stock options and a same-day sale of common stock in Twist Bioscience Corp (NASDAQ:TWST) on August 7, 2026, pursuant to a Rule 10b5-1 trading plan.
A Form 4 filed on August 11, 2026 reports that Bradley J. Peterson, Executive Vice President and Chief Information Officer of Nasdaq, Inc. (NASDAQ:NDAQ), disposed of 6,000 shares of common stock on August 7, 2026.
Scot Greulach, Chief Accounting Officer of Stanley Black & Decker, Inc., filed a Form 4 on August 11, 2026, disclosing the sale of 1,015 shares of common stock on August 7, 2026.
Silver Point Capital L.P., along with affiliated reporting persons Edward A. Mule and Robert J. O'Shea, filed a Form 4 on August 11, 2026, disclosing the sale of American Depositary Shares in Studio City International Holdings Ltd, traded on NYSE as MSC, with the …
A Form 4 filed on August 11, 2026 discloses that Mary Beth Wilkinson, Executive Vice President, Chief Legal Officer, and Secretary of KLA Corp (NASDAQ:KLAC), sold 1,661 shares of KLA common stock on August 10, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.